OAM
GILD icon

Optimal Asset Management’s Gilead Sciences GILD Stock Holding History

Optimal Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1.78M Buy
25,474
+27
+0.1% +$1.9K 0.22% 156
2021
Q2 		$1.75M Hold
25,447
– – 0.21% 173
2021
Q1 		$1.65M Buy
+25,447
New +$1.64M 0.21% 167

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Optimal Asset Management's GILD Position: Q3 2021 in Review

Optimal Asset Management increased its Gilead Sciences (GILD) stake by 0.11% in Q3 2021, buying an estimated $1.9K and bringing the position to 25,474 shares worth $1.78M. The position accounts for 0.22% of the portfolio, ranked #156.

Optimal Asset Management first reported a position in GILD in Q1 2021 and has held it in 3 quarters since. 1,563 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

  • Optimal Asset Management held 25,474 shares of Gilead Sciences worth $1.78M as of Q3 2021.
  • Optimal Asset Management bought 27 Gilead Sciences shares in Q3 2021, an estimated $1.9K.
  • Gilead Sciences made up 0.22% of Optimal Asset Management's portfolio in Q3 2021, its #156 holding.
  • Optimal Asset Management first reported a position in Gilead Sciences in Q1 2021 and has held it in 3 quarters since.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on Optimal Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.